Irinotecan Hydrochloride Injection, Solution
Product Images NDC 60505-6272

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 60505-6272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5ml-carton (5ml Carton)

FDA Label Image

5ml-container (5ml Container)

FDA Label Image

Figure 1 Survival First-line Irinotecan/5-fu/lv Vs 5-fu/lv Study 1 (Figure 1)

FDA Label Image

Figure 2 Survival First-line Irinotecan/5-fu/lv Vs 5-fu/lv Study 2 (Figure 2)

FDA Label Image

Figure 3. Survival Second-line Irinotecan Vs Best Supportive Care (bsc) Study 7 (Figure 3)

FDA Label Image

Figure 4. Survival Second-line Irinotecan Vs Infusion 5-fu Study 8 (Figure 4)

Figure 4. Survival Second-line Irinotecan Vs Infusion 5-fu Study 8 (Figure 4)
Not available*
FDA Label Image

Irinotecan Hydrochloride Structural Formula (Irinotecan Hydrochloride)

FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.